FR2317912A1 - Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central - Google Patents

Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central

Info

Publication number
FR2317912A1
FR2317912A1 FR7621862A FR7621862A FR2317912A1 FR 2317912 A1 FR2317912 A1 FR 2317912A1 FR 7621862 A FR7621862 A FR 7621862A FR 7621862 A FR7621862 A FR 7621862A FR 2317912 A1 FR2317912 A1 FR 2317912A1
Authority
FR
France
Prior art keywords
acting
pharmaceutical composition
nervous system
central nervous
parenteral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7621862A
Other languages
English (en)
Other versions
FR2317912B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FR2317912A1 publication Critical patent/FR2317912A1/fr
Application granted granted Critical
Publication of FR2317912B1 publication Critical patent/FR2317912B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR7621862A 1975-07-16 1976-07-16 Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central Granted FR2317912A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/596,488 US4016273A (en) 1975-07-16 1975-07-16 Sustained release forms of certain oxazepines for parenteral administration

Publications (2)

Publication Number Publication Date
FR2317912A1 true FR2317912A1 (fr) 1977-02-11
FR2317912B1 FR2317912B1 (fr) 1979-04-13

Family

ID=24387483

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7621862A Granted FR2317912A1 (fr) 1975-07-16 1976-07-16 Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central

Country Status (11)

Country Link
US (1) US4016273A (fr)
BE (1) BE844203A (fr)
CA (1) CA1062159A (fr)
DE (1) DE2630394A1 (fr)
DK (1) DK319776A (fr)
FI (1) FI762053A (fr)
FR (1) FR2317912A1 (fr)
GB (1) GB1525425A (fr)
NL (1) NL7607918A (fr)
PT (1) PT65358B (fr)
SE (1) SE7608114L (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002013870A2 (fr) * 2000-08-17 2002-02-21 Mitokor, Inc. Nouvelles formulations destinees a l'administration de molecules therapeutiques lipophiles

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617321B2 (en) 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US6199634B1 (en) 1998-08-27 2001-03-13 Viatchelav Ivanovich Selyakov Method and apparatus for controlling the permeability of mineral bearing earth formations
DK1274459T3 (da) * 2000-04-19 2006-02-06 Genentech Inc Præparater med vedholdende frigivelse indeholdende væksthormon
DE10059020A1 (de) * 2000-11-28 2002-05-29 Gruenenthal Gmbh Parenteral applizierbare Darreichungsformen
WO2003000282A1 (fr) * 2001-06-21 2003-01-03 Genentech, Inc. Formulation a liberation lente
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US6972195B2 (en) * 2002-09-27 2005-12-06 Rongxiang Xu Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
RU2006128593A (ru) * 2004-01-07 2008-02-20 Тримерис, Инк. (Us) Синтетические пептиды, производные области hr2 белка gp41 вич, и их применение в терапии для ингибирования проникновения вируса иммунодефицита человека
ATE511512T1 (de) * 2005-01-05 2011-06-15 Lilly Co Eli Olanzapinpamoat-dihydrat
AR059300A1 (es) * 2006-02-02 2008-03-26 Trimeris Inc Peptidos inhibidores de la fusion de vih con propiedades biologicas mejoradas
DK1884507T3 (da) * 2006-07-27 2010-08-16 Cognis Ip Man Gmbh Fremgangsmåde til fremstilling af glycerol
MX2009010689A (es) * 2007-04-03 2009-12-14 Trimeris Inc Formulaciones novedosas para el suministro de agentes terapeuticos de peptidos antivirales.
BRPI0817697A2 (pt) * 2007-09-25 2015-04-07 Trimeris Inc Método de síntese de um peptídeo, conjunto de fragmentos de peptídeo, e, peptídeo

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3546226A (en) * 1963-03-01 1970-12-08 A Wander Sa Dr 11-basic-substituted dibenzoxazepines
US3663696A (en) * 1966-05-20 1972-05-16 American Cyanamid Co Treatment of depression with 2-chloro-11 - (piperazinyl)dibenz - (b,f)(1,4)oxazepines and acid addition salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3164520A (en) * 1962-10-29 1965-01-05 Olin Mathieson Injectable steroid compositions containing at least 75% benzyl benzoate
US3538216A (en) * 1964-02-20 1970-11-03 Lab De Rech Physiques S A R L Injectable compositions of a drug suspended in an emulsion
US3546220A (en) * 1966-08-01 1970-12-08 Abbott Lab 2,3-dihydro-1h-pyrido-(2,3-b)(1,4)thiazines
US3549621A (en) * 1968-04-29 1970-12-22 Harry Louis Yale 12-substituted-6h-dibenz(b,f)(1,4)oxazocin-11(12h) ones
US3891647A (en) * 1970-08-06 1975-06-24 Wander Ag Dr A 2-trifluoromethyl-sulphonyl-11-substituted-piperazinyl-dibenz {8 b,f{9 {8 1,4{9 {0 oxazepine
US3773768A (en) * 1970-10-26 1973-11-20 American Cyanamid Co 7-amino-2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine and salts thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3546226A (en) * 1963-03-01 1970-12-08 A Wander Sa Dr 11-basic-substituted dibenzoxazepines
US3663696A (en) * 1966-05-20 1972-05-16 American Cyanamid Co Treatment of depression with 2-chloro-11 - (piperazinyl)dibenz - (b,f)(1,4)oxazepines and acid addition salts thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002013870A2 (fr) * 2000-08-17 2002-02-21 Mitokor, Inc. Nouvelles formulations destinees a l'administration de molecules therapeutiques lipophiles
WO2002013870A3 (fr) * 2000-08-17 2003-02-06 Apollo Biopharmaceutics Inc Nouvelles formulations destinees a l'administration de molecules therapeutiques lipophiles

Also Published As

Publication number Publication date
GB1525425A (en) 1978-09-20
FI762053A (fr) 1977-01-17
FR2317912B1 (fr) 1979-04-13
NL7607918A (nl) 1977-01-18
PT65358B (en) 1978-01-09
SE7608114L (sv) 1977-01-17
BE844203A (fr) 1977-01-17
DK319776A (da) 1977-01-17
CA1062159A (fr) 1979-09-11
DE2630394A1 (de) 1977-02-03
PT65358A (en) 1976-08-01
US4016273A (en) 1977-04-05

Similar Documents

Publication Publication Date Title
BE849632A (fr) Composition pharmaceutique pour l'administration orale
RO68479A (fr) Procede pour la preparation des 1,4-dihydropyridinecarboxylates d'aralkyle
BE847283A (fr) Nouveaux medicaments derives de l'indole,
FR2317912A1 (fr) Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central
FR2321655A1 (fr) Moderateur de debit, notamment pour dispositifs d'injection intraveineuse
RO69608A (fr) Procede pour la preparation des 1,2-benzisothiazole-3-ones
FR2333521A1 (fr) Dispositif d'administration d'un liquide par voie parenterale
BE819033A (fr) Procede pour la preparation de 3-(3,4-dihydro-xy-phenyl)-serine
BE838823A (fr) Procede pour la preparation de 1,2,5-dihydroxycholecalciferol
RO72547A (fr) Procede pour la preparation des esters 2',3,6'-trichlore-4-cyan-4'-benzoylureidodiphenyliques
FR2335522A1 (fr) Procede de preparation d'androstene-4 diones-3,17
FR2301976A1 (fr) Systeme de reglage pour le retablissement de l'ortho
RO76667A (fr) Procede pour la preparation des 2,4-dialkyamino-6-chlore-5-triazines
BE845327A (fr) Procede de preparation de 4,4'-dihydroxy-3-3'-5-5'-tretralcoyldiphenylalcanes
PT64691B (fr) Procede pour la preparation d'acides 6,11-di-hydro-11-oxo-dibenz /b,e/ oxepin-alcanoiques
RO70232A (fr) Procede pour la preparation des 4-pyrazolile-4h-1,2,4-triazolile
BR7409983A (pt) Processo aperfeicoado para a preparacao de n,n,n',n'-tetrafenildiamino-metano
BE845017A (fr) Procede pour l'obtention d'alpha,alpha,alpha,alpha',alpha',-pentachloro-o-xylene
DK138895B (da) Fremgangsmåde til fremstilling af 8-beta-(2'-pyrimidino-aminometyl)-ergolinderivater.
FR2318166A1 (fr) Procede de preparation continue de 2,5-dioxo-1-oxa-2-phospholanes
CA1035359A (fr) Derives de tetrahydro-1,2,3,4 isoquinoline substitues en 1 et disubstitues en 6,7
BE810385A (fr) Compositions medicamenteuses pour l'administration par voie orale
PH10997A (en) 4-h-benzo(4,5)cyclochepta-(1,2-b)thiophen derivatives and pharmaceutical composition thereof
RO63736A (fr) Procede pour la preparation d'alcaloides m-formyldiindoliques
BE809592A (fr) Procede pour la preparation de 2,2'-anhydro-1-d-arabinofuranosyl-5-fluorocytosine

Legal Events

Date Code Title Description
ST Notification of lapse